PLANO, Texas, July 20 /PRNewswire-FirstCall/ -- AUSTIN MEDICAL TECHNOLOGIES, Inc. (OTC Pink Sheets: AMTK), dba eyeDirecti, announces the appointment of Denice Espinosa, CRNA to the company Board of Advisors.
Denice Espinosa, CRNA is the Director of Surgery and Refractive Centers/Anesthesia for Berkeley Eye Center in Houston and oversees all surgical services provided in the Caplan Surgery Center and Berkeley-Caplan Laser Centers, as well as all ophthalmic surgical services provided by Berkeley Eye Center surgeons in five outlying ambulatory surgery centers/hospitals. Ms. Espinosa is responsible for system analysis of the surgical process, to include time and cost analysis for surgery and laser center caseloads. She has been a customer of eyeDirecti for over three years, using daypacks with great savings and success.
Denice Espinosa states, “I am very excited to become a part of such a dynamic group of individuals. I have been a customer of eyeDirecti for over three years and the company has shown me time after time that the value of flexibility and reliability is immeasurable. The cost savings that the custom daypacks(TM) have offered for Berkeley Eye Center through the products and the reduction of employee time spent in preparation for surgery have been substantial enough to keep Berkeley Eye Center/Caplan Surgery Center coming back for more business. I look forward to the opportunity to contribute to the growth of eyeDirecti by providing insight into processes that influence the success of surgery and laser centers.”
About Denice Espinosa, CRNA:
Denice Espinosa attended the University of Texas in Austin for two years and the University of Texas in Houston for two years to complete her Bachelor of Science degree in nursing. She practiced nursing in the Texas Medical Center for ten years before returning to graduate school at the University of Texas in Houston. She completed her studies and attained a Masters of Science degree in nursing, with a specialty in anesthesia, and became a Certified Registered Nurse Anesthetist. Ms. Espinosa has been the Director of Surgery and Refractive Centers/Anesthesia at Berkeley Eye Center for the past five years and has played an integral role in the design and function of Berkeley- Caplan Laser Centers and Caplan Surgery Center. She currently practices anesthesia at the Caplan Surgery Center as well as at Lyndon B. Johnson Harris County Hospital. She is an active member of the Ophthalmic Anesthesia Society, Ophthalmic Administrators Society, and the American Association of Nurse Anesthetists.
About Austin Medical Technologies, Inc./eyeDirecti(TM) (Brand)
Austin Medical Technologies delivers “DIRECT” from the manufacturer to the Surgeon, the only technology based, “Single Source Supply Solution” for custom sterile surgery trays made up of 80% of all disposable surgical devices utilized in surgery. Currently the company has contracted with nearly 200 eye surgery centers including the 2 largest eye surgery centers in the USA. The market for custom sterile surgery trays is a $2.1 Billion market here in the USA.
Austin Medical is dedicated exclusively to the Ambulatory Surgery Center (ASC) market. Ambulatory Surgery Centers (ASC), also called outpatient surgery, and same-day surgery, refers to surgical procedures which are complex enough to require a dedicated operating room and specially trained staff, but do not require an overnight stay. According to 1996 U.S. government statistics, ambulatory surgery centers account for 31 million or 44% of the total surgeries performed in the United States. Five million surgeries were performed on eyes. New surgical techniques such as laser surgery allow procedures to be done more quickly and/or with less surgical trauma.
Under the brand name eyeDirecti, Austin Medical is initially focused on Ophthalmology owned and operated surgery centers which is the fastest growing segment of the ASC market, growing by 25% per annum, consisting of 2,500 practices with 15,000 surgeons performing over 5 million surgical procedures annually at a supply cost of $400,000,000 per year. Austin Medical is positioned to capture $40,000,000 (10%) of this $400,000,000 market within the next 4 years. Visit our e-commerce site at http://www.eyedirecti.com/ .
Note: Any statements released by Austin Medical Technologies, Inc., or any of its affiliates that are forward-looking, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act. Editors and investors are cautioned that forward-looking statements invoke risk and uncertainties that may affect the Company’s business prospects and performances. These include economic, competitive, governmental, technological and other factors discussed in the statements and in the Company’s filings with the Securities and Exchange Commission.
Austin Medical Technologies, Inc.
CONTACT: Keith Tarter of Austin Medical Technologies, Inc.,+1-972-370-0197, or investors@austinmedtech.com
